Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cape Bear Advisors is a boutique strategic advisory firm dedicated to the life sciences and biotechnology sectors. The firm specializes in providing high-level guidance on corporate strategy, financial management, and capital allocation for biopharmaceutical companies. Founded by Paul Clancy, the former Chief Financial Officer of Biogen and Alexion Pharmaceuticals, the firm leverages deep industry expertise to support executive teams and boards of directors. Cape Bear Advisors focuses on helping clients navigate complex business environments, including mergers and acquisitions, business development, and long-term value creation. The firm is primarily known for its principal's extensive track record in scaling large-cap biotech organizations and managing sophisticated financial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cape Bear Advisors.